Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
9.28
-1.07 (-10.34%)
At close: Feb 21, 2025, 4:00 PM
9.27
-0.01 (-0.11%)
After-hours: Feb 21, 2025, 7:59 PM EST
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $3.66 billion as of February 21, 2025. Its market cap has increased by 78.23% in one year.
Market Cap
3.66B
Enterprise Value
3.32B
1-Year Change
78.23%
Ranking
Category
Stock Price
$9.28
Market Cap Chart
Since the IPO on April 16, 2021, Recursion Pharmaceuticals's market cap has increased from $2.92B to $3.66B, an increase of 25.40%. That is a compound annual growth rate of 6.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.66B | 37.28% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -0.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 789.88B |
| UnitedHealth Group | 428.70B |
| Johnson & Johnson | 391.14B |
| Novo Nordisk | 370.84B |
| AbbVie | 357.80B |
| Abbott Laboratories | 233.64B |
| AstraZeneca | 229.50B |
| Merck & Co. | 224.49B |